首页 > 分享 > 新生血管性青光眼的发病机制及治疗进展

新生血管性青光眼的发病机制及治疗进展

新生血管性青光眼的发病机制及治疗进展

基金项目:

深圳市科技计划项目(No. JCYJ20160428144848002)

Pathogenesis and treatment of neovascular glaucoma

Author:

Chen Shangrui

Chen Shangrui

The Second Clinical Medical College of Jinan University, Shenzhen 518020, Guangdong Province, China
在期刊界中查找
在百度中查找
在本站中查找

Lai Mingying

Lai Mingying

Shenzhen Eye Hospital Affiliated to Jinan University, Shenzhen 518040, Guangdong Province, China
在期刊界中查找
在百度中查找
在本站中查找

Lin Peijie

Lin Peijie

Shenzhen Eye Hospital Affiliated to Jinan University, Shenzhen 518040, Guangdong Province, China
在期刊界中查找
在百度中查找
在本站中查找

Fund Project:

Science and Technology Project of Shenzhen(No.JCYJ20160428144848002)

摘要 | | 访问统计 | 参考文献 [51] | | || 文章评论

摘要:

新生血管性青光眼属于难治性青光眼,病理表现为虹膜及房角新生血管形成、新生血管膜收缩牵拉,使虹膜和房角黏连关闭,阻碍房水外流导致眼压升高,产生剧烈眼痛或头痛,进而损害视神经,造成视力急剧下降,严重者可导致失明。目前,治疗新生血管性青光眼主要有全视网膜激光光凝术、注射抗血管内皮生长因子、局部或全身应用降眼压药物以及抗青光眼手术等多种方法,从而尽可能地减少新生血管形成、保留视功能和改善症状。但由于新生血管性青光眼复杂的发病机制和病理改变,在临床上其治疗较原发性青光眼更为困难,预后也更差。因此,通过了解其发病机制和治疗方法,可以更好地在不同病情下选择最科学的治疗策略。故文章将对新生血管性青光眼的发病机制和治疗进行归纳和总结,并作一综述。

Abstract:

Neovascular glaucoma is classified as a type of refractory glaucoma. Its pathological manifestation is the formation of neovascularization of iris and chamber angle, and then the formation of neovascularization membrane. The contraction and traction of neovascularization membrane make the iris and chamber angle adhesion close, which leads to the obstruction of aqueous humor outflow and the sharp increase of intraocular pressure. Excessive intraocular pressure not only causes severe headache and eye pain, but also damages the optic nerve and affects the patient's vision, which can lead to blindness. At present, there are many methods for the treatment of neovascular glaucoma, such as panretinal photocoagulation, anti-vascular endothelial growth factor, local or systemic administration of intraocular pressure lowering drugs and anti-glaucoma surgery. The aim is to reduce neovascularization, preserve visual function and improve symptoms as much as feasible. However, due to the complex pathogenesis and pathological changes of neovascular glaucoma, the treatment of neovascular glaucoma is more difficult than primary glaucoma, and the prognosis is worse. Understanding its pathogenesis and treatment methods can aid in selecting the most appropriate treatment strategy based on individual circumstances. Therefore, this review will summarize the pathogenesis and treatment of neovascular glaucoma.

引用本文

陈尚瑞,赖铭莹,林佩洁.,等.新生血管性青光眼的发病机制及治疗进展.国际眼科杂志, 2024,24(10):1605-1609.

复制

分享 文章指标 点击次数:4 下载次数: 17 HTML阅读次数: 0 历史 收稿日期:2024-03-09 最后修改日期:2024-08-23 在线发布日期: 2024-09-14

相关知识

【春天的苦恼】花粉症
养花治疗精神病的药物
滕州市中心人民医院开展阿尔茨海默病靶向药物治疗
植物神经紊乱引起的失眠吃什么药治疗
医生您好,我想咨询您一下,康仙花和迷迭香能不能混一起泡水喝呀?不会相克或者有什么副作用吧?谢谢
郑新运用参芪地黄汤联合火把花根片治疗膜性肾病经验
花卉真菌性病害的发病部位和症状(10页)
曲剑华凉血五花汤治疗玫瑰痤疮经验
什么花在秋天开
植物疗法和物理疗法治疗慢性前列腺炎

网址: 新生血管性青光眼的发病机制及治疗进展 https://m.huajiangbk.com/newsview164849.html

所属分类:花卉
上一篇: 来自吉林!创下多个首次!历史性突
下一篇: 中医如何治疗足癣